The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
The search session has expired. Please query the service again.
Despite recent advances, treatment of patients with aggressive Non-Hodgkin's
lymphoma (NHL) has yet to be optimally designed. Notwithstanding the contribution of
molecular treatments, intensification of chemotherapeutic regimens may still be beneficial.
Hoping to aid in the design of intensified chemotherapy, we put forward a mathematical
and computational model that analyses the effect of Doxorubicin on NHL over a wide
range of patho-physiological conditions. The model represents tumour growth...
Download Results (CSV)